Journal article
Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
Science advances, Vol.8(29), pp.eabk3150-eabk3150
07/22/2022
DOI: 10.1126/sciadv.abk3150
PMCID: PMC9299550
PMID: 35857851
Abstract
In clinical settings, cancer vaccines as monotherapies have displayed limited success compared to other cancer immunotherapeutic treatments. Nanoscale formulations have the ability to increase the efficacy of cancer vaccines by combatting the immunosuppressive nature of the tumor microenvironment. Here, we have synthesized a previously unexplored cationic polymeric nanoparticle formulation using polyamidoamine dendrimers and poly(d,l-lactic-co-glycolic acid) that demonstrate adjuvant properties in vivo. Tumor-challenged mice vaccinated with an adenovirus-based cancer vaccine [encoding tumor-associated antigen (TAA)] and subsequently treated with this nanoparticulate formulation showed significant increases in TAA-specific T cells in the peripheral blood, reduced tumor burden, protection against tumor rechallenge, and a significant increase in median survival. An investigation into cell-based pathways suggests that administration of the nanoformulation at the site of the developing tumor may have created an inflammatory environment that attracted activated TAA-specific CD8+ T cells to the vicinity of the tumor, thus enhancing the efficacy of the vaccine.
Details
- Title: Subtitle
- Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
- Creators
- Rasheid Smith - University of IowaEmad I Wafa - University of IowaSean M Geary - University of IowaKareem Ebeid - University of IowaSuhaila O Alhaj-Suliman - University of IowaAliasger K Salem - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Science advances, Vol.8(29), pp.eabk3150-eabk3150
- DOI
- 10.1126/sciadv.abk3150
- PMID
- 35857851
- PMCID
- PMC9299550
- NLM abbreviation
- Sci Adv
- eISSN
- 2375-2548
- Language
- English
- Date published
- 07/22/2022
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Pharmaceutical Sciences and Experimental Therapeutics; Craniofacial Anomalies Research Center; Dental Research; Chemical and Biochemical Engineering
- Record Identifier
- 9984296966202771
Metrics
16 Record Views